Company Overview and News

 
Millennium exceeds production guidance at Nullagine

2018-10-02 australianmining.com.au
Millennium Minerals has beaten its September quarter gold production guidance at the Nullagine gold mine in the East Pilbara of Western Australia.
MOY MMMDF

 
Millennium to hit top-end guidance

2018-10-02 businessnews.com.au
Local gold producer Millennium Minerals says it is on course to hit the top end of its guidance for 2018 on the back of a strong second half performance.
MOY MMMDF

 
Millennium identifies ‘breakthrough’ gold target at Nullagine using new technology

2018-08-28 australianmining.com.au
Millennium Minerals has identified a major greenfields exploration target at Golden Eagle, the company’s largest gold deposit at the Nullagine project in the Pilbara region.
MOY MMMDF

 
Millennium Minerals increases Nullagine gold ore reserves by 38%

2018-07-31 proactiveinvestors.com.au
Millennium Minerals Ltd (ASX:MOY) has increased ore reserves at its Nullagine Gold Project in Western Australia by 38%, to a total of 304,700 ounces of gold.
MOY MMMDF

 
Millennium Minerals updates Redbeard gold ore reserve, mining to start this month

2018-07-03 proactiveinvestors.com.au
Millennium Minerals Ltd (ASX:MOY) has upgraded the probable ore reserve for Redbeard open pit oxide deposit within its Nullagine project area, prior to the start of mining later this month.
MOY MMMDF

6
International Prospect Ventures Enters Into LOI for Acquisition of an NSR on the Comet Well Property in Western Australia

2018-06-28 globenewswire
THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWS AGENCIES
MOY PACXF MMMDF NSRPF DTEMF NVO MALRY MALRF MIN

 
Millennium on track to hit 100,000oz gold target

2018-06-25 australianmining.com.au
Millennium Minerals is set to bring its sixth and new mining centre at the Nullagine gold project in the Pilbara region of Western Australia next month, following a resource grade increase in the latest Redbeard oxide resource drilling.
MOY MMMDF

 
Millennium secures $18m loan facility

2018-06-06 businessnews.com.au
Millennium Minerals has secured a $17.5 million loan facility with Investec to fund an expansion of the company’s Nullagine gold project in the Pilbara.
MOY MMMDF

 
Millennium Minerals secures $17.5m for WA plant expansion

2018-06-06 australianmining.com.au
Perth-based Millennium Minerals has received a $17.5 million funding commitment from Investec Australia to expand the processing plant at its Nullagine gold project in the Western Australia.
MOY MMMDF

 
Millennium Minerals targets gold production of up to 80,000 ounces at Nullagine in 2018

2018-03-19 proactiveinvestors.com.au
Millennium Minerals Ltd’s (ASX:MOY) expects to achieve gold production in a range between 75,000 ounces and 80,000 ounces in 2018.
MOY MMMDF

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to ASX:MOY / MILLENNIUM MINERALS LIMITED on message board site Silicon Investor.

Moyco CMP Slurries - CEO Says Moyco CMP Slurries - CEO Says Moyco CMP Slurries - CEO Says MOYDOW MINES (MOY.TO) MOYDOW MINES (MOY.TO) MOYDOW MINES (MOY.TO)